APA (7th ed.) Citation

Alsmadi, M. M., & Alzughoul, S. B. (2023). In vitro–in vivo extrapolation of bexarotene metabolism in the presence of chronic kidney disease and acute kidney injury in rat using physiologically based pharmacokinetic modeling and extrapolation to human. Biopharmaceutics & drug disposition, 44(3), 221-244. https://doi.org/10.1002/bdd.2337

Chicago Style (17th ed.) Citation

Alsmadi, Mo'tasem M., and Saja B. Alzughoul. "In Vitro–in Vivo Extrapolation of Bexarotene Metabolism in the Presence of Chronic Kidney Disease and Acute Kidney Injury in Rat Using Physiologically Based Pharmacokinetic Modeling and Extrapolation to Human." Biopharmaceutics & Drug Disposition 44, no. 3 (2023): 221-244. https://doi.org/10.1002/bdd.2337.

MLA (9th ed.) Citation

Alsmadi, Mo'tasem M., and Saja B. Alzughoul. "In Vitro–in Vivo Extrapolation of Bexarotene Metabolism in the Presence of Chronic Kidney Disease and Acute Kidney Injury in Rat Using Physiologically Based Pharmacokinetic Modeling and Extrapolation to Human." Biopharmaceutics & Drug Disposition, vol. 44, no. 3, 2023, pp. 221-244, https://doi.org/10.1002/bdd.2337.